MedPath

Effectiveness of Tranexamic acid in reducing blood loss during myomectomy in federal Medical Centre, Owerri: A randomised controlled trial

Not Applicable
Recruiting
Conditions
Uterine fibroid
Registration Number
PACTR202001691971779
Lead Sponsor
Onwukwe Emeka
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Female
Target Recruitment
60
Inclusion Criteria

1) Consenting women scheduled to have abdominal (laparotomy and ) myomectomy
2) uterine size of 16 weeks and above with multiple uterine fibroids

Exclusion Criteria

1) women with known allergy to Tranexamic acid
2) women with current and / or previous thromboembolic disease
3) women with bleeding disorders
4) women taking combine oral contraceptive pills
5) women who had received Gonadotrophin Releasing hormone analogue within three month of the proposed surgery
6) women who are receiving Tranexamic acid for menorrhagia within one month of surgery

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Estimated intraoperative blood loss
Secondary Outcome Measures
NameTimeMethod
Packed cell volume postoperative;Number of participants requiring blood transfusion;The number of units of whole blood transfused;Duration of sugery
© Copyright 2025. All Rights Reserved by MedPath